The Impact Triad (Severity, Importance, Self-management) as a Method of Enhancing Measurement of Personal Life Impact of Rheumatic Diseases

REFERENCES

1. 1.↵
   1. Kalyoncu U,
   2. Dougados M,
   3. Daures J,
   4. Gossec L

   . Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: A systematic literature review. Ann Rheum Dis 2009;68:183–90.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Food and Drug Administration

   . Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labelling claims. 18 December 2009, UCM 193282. [Internet. Accessed September 27, 2010.] Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf
3. 3.↵
   1. Hewlett S

   . Patients and clinicians have different perspectives on outcomes in arthritis. J Rheumatol 2003;30:877–9.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Hewlett S,
   2. Sanderson T,
   3. May J,
   4. O’Bingham C,
   5. March L,
   6. Alten R,
   7. et al.

   “Just shoot me”: RA patients experience flare as more than painful, swollen joints [abstract]. Rheumatology 2010;49 Suppl 1:i141.

   OpenUrlCrossRef
5. 5.↵
   1. Sanderson T,
   2. Morris M,
   3. Calnan M,
   4. Richards P,
   5. Hewlett S

   . Patient perspective of measuring treatment efficacy: the Rheumatoid Arthritis Patient Priorities for Pharmacological Interventions (RAPP-PI) outcomes. Arthritis Care Res 2010;62:647–56.

   OpenUrlCrossRef
6. 6.↵
   1. Nicklin J,
   2. Cramp F,
   3. Kirwan J,
   4. Greenwood R,
   5. Urban M,
   6. Hewlett S

   . Measuring fatigue in RA: A cross sectional study to evaluate the Bristol RA Fatigue Multi-Dimensional Questionnaire, Visual Analogue and Numerical Rating Scales (BRAF). Arthritis Care Res 2010 Jun 25. Epub ahead of print
7. 7.↵
   1. Gately C,
   2. Rogers A,
   3. Sanders C

   . Re-thinking the relationship between long-term condition self-management education and the utilisation of health services. Soc Sci Med 2007;65:934–45.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Department of Health

   . National service framework for long-term conditions. London: Department of Health; 2005.
9. 9.↵
   1. Kralik D,
   2. Koch T,
   3. Price K,
   4. Howard N

   . Patient involvement in clinical nursing, J Clin Nurs 2004;13:259–67.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. van der Heijde D,
    2. Hof M,
    3. Piet L,
    4. Putte L

    . Development of a disease activity score based on judgement in clinical practice by rheumatologists. J Rheumatol 1993;20:579–81.

    OpenUrlPubMed
11. 11.↵
    1. Gossec L,
    2. Dougados M,
    3. Rincheval N,
    4. Balanescu A,
    5. Boumpas DT,
    6. Canadelo S,
    7. et al.

    The elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: A EULAR initiative. Ann Rheum Dis 2009;36:2097–9.

    OpenUrl
12. 12.↵
    1. Tugwell P,
    2. Bombardier C,
    3. Buchanan WW,
    4. Goldsmith CH,
    5. Grace E,
    6. Hanna B

    . The MACTAR Patient Preference Disability Questionnaire: An individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol 1987;14:446–51.

    OpenUrlPubMed
13. 13.↵
    1. O’Boyle CA,
    2. McGee H,
    3. Hickey A,
    4. Joyce CRB,
    5. Browne J,
    6. O’Malley K,
    7. et al.

    The schedule for evaluation of individual quality of life. User manual. Dublin: Department of Psychology, Royal College of Surgeons in Ireland; 1993.
14. 14.↵
    1. Hewlett S,
    2. Smith AP,
    3. Kirwan JR

    . Measuring the meaning of disability in rheumatoid arthritis: the Personal Impact Health Assessment Questionnaire (PI HAQ). Ann Rheum Dis 2002;61:986–93.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Verhoeven AC,
    2. Boers M,
    3. van der Liden S

    . Validity of the MACTAR questionnaire as a functional index in a rheumatoid arthritis clinical trial. J Rheumatol 2000;27:2801–9.

    OpenUrlPubMed
16. 16.↵
    1. Seror R,
    2. Tubach F,
    3. Baron G,
    4. Guillemin F,
    5. Ravaud P

    . Measure of function in rheumatoid arthritis: individualised or classical scales? Ann Rheum Dis 2010;69:97–101.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. ten Klooster PM,
    2. Taal E,
    3. Veehof MM,
    4. vand de Laar AFJ

    . Changes in priorities for health status improvement in patients with rheumatoid arthritis after TNF-blocking treatment [abstract]. Arthritis Rheum 2006;54 Suppl:S768.

    OpenUrl
18. 18.↵
    1. Hewlett S,
    2. Cockshott Z,
    3. Kirwan J,
    4. Barrett J,
    5. Stamp J,
    6. Haslock I

    . Development and validation of a self-efficacy scale for use in British patients with rheumatoid arthritis (RASE). Rheumatology 2001;40:1221–30.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Ahmed S,
    2. Mayo NE,
    3. Wood-Dauphinee S,
    4. Hanley JA,
    5. Cohen SR

    . Response shift influenced estimates of change in health-related quality of life poststroke. J Clin Epidemiol 2004;57:561–70.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Ring L,
    2. Hofer S,
    3. Heuston F,
    4. Harris D,
    5. O’Boyle CA

    . Response shift masks the treatment impact on patient reported outcomes (PROs): The example of individual quality of life in edentulous patients. Health Qual Life Outcomes 2005;3:55.

    OpenUrlCrossRefPubMed